iX Biopharma Ltd.
Status: Publicly traded
Direct answer
iX Biopharma Ltd. is publicly traded on SES under the ticker 42C.SI.
iX Biopharma Ltd., a specialty pharmaceutical and nutraceutical enterprise headquartered in Singapore since its inception in 2004, focuses on the research, development, manufacturing, and commercialization of therapeutic solutions. The company targets acute and breakthrough pain, alongside various other health conditions, serving markets in Singapore, the United States, China, and Australia through its Specialty...
Can you invest in iX Biopharma Ltd.?
Yes. iX Biopharma Ltd. is publicly traded on SES under the ticker 42C.SI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for iX Biopharma Ltd.
Detailed equity research is provided by MarketSnap.